These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1995531

  • 41. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
    Adams GE, Stratford IJ, Edwards HS, Bremner JC, Cole S.
    Int J Radiat Oncol Biol Phys; 1992; 22(4):717-20. PubMed ID: 1544844
    [Abstract] [Full Text] [Related]

  • 42. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors.
    Shulman LN, Buswell L, Riese N, Doherty N, Loeffler JS, von Roemeling RW, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):349-53. PubMed ID: 10760430
    [Abstract] [Full Text] [Related]

  • 43. Effect of normobaric oxygen on tumor radiosensitivity: fractionated studies.
    Rojas A, Carl U, Reghebi K.
    Int J Radiat Oncol Biol Phys; 1990 Mar 01; 18(3):547-53. PubMed ID: 2108105
    [Abstract] [Full Text] [Related]

  • 44. A simple method of producing low oxygen conditions with oxyrase for cultured cells exposed to radiation and tirapazamine.
    Ho KC, Leach JK, Eley K, Mikkelsen RB, Lin PS.
    Am J Clin Oncol; 2003 Aug 01; 26(4):e86-91. PubMed ID: 12902904
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [In vitro oxygen-dependent survival of 2 human cell lines after radiation combined with tirapazamine (SR-4233) and cisplatin].
    Lartigau E, Stern S, Guichard M.
    Cancer Radiother; 2000 Aug 01; 4(3):217-22. PubMed ID: 10897765
    [Abstract] [Full Text] [Related]

  • 47. Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas.
    Zips D, Le K, Yaromina A, Dörfler A, Eicheler W, Zhou X, Geyer P, Hilberg F, Baumann M.
    Radiother Oncol; 2009 Sep 01; 92(3):405-10. PubMed ID: 19409639
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
    Zheng H, Olive PL.
    Cancer Res; 1996 Jun 15; 56(12):2801-8. PubMed ID: 8665517
    [Abstract] [Full Text] [Related]

  • 50. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, Hori H, Nagasawa H, Uto Y, Tsuchiya I, Sadahiro S, Murayama C.
    Int J Radiat Oncol Biol Phys; 2001 Jul 15; 50(4):1063-72. PubMed ID: 11429234
    [Abstract] [Full Text] [Related]

  • 51. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
    Koch CJ.
    Cancer Res; 1993 Sep 01; 53(17):3992-7. PubMed ID: 8358728
    [Abstract] [Full Text] [Related]

  • 52. Chemical radiosensitizers for use in radiotherapy.
    Wardman P.
    Clin Oncol (R Coll Radiol); 2007 Aug 01; 19(6):397-417. PubMed ID: 17478086
    [Abstract] [Full Text] [Related]

  • 53. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
    Evans SM, Jenkins WT, Shapiro M, Koch CJ.
    Adv Exp Med Biol; 1997 Aug 01; 411():215-25. PubMed ID: 9269430
    [Abstract] [Full Text] [Related]

  • 54. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ, Horsman MR, Aoki DS.
    Br J Cancer; 1991 Jan 01; 63(1):109-13. PubMed ID: 1846549
    [Abstract] [Full Text] [Related]

  • 55. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
    Rojas A, Joiner MC, Hodgkiss RJ, Carl U, Kjellen E, Wilson GD.
    Int J Radiat Oncol Biol Phys; 1992 Jan 01; 23(2):361-6. PubMed ID: 1587757
    [Abstract] [Full Text] [Related]

  • 56. Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice.
    Walton MI, Workman P.
    J Pharmacol Exp Ther; 1993 May 01; 265(2):938-47. PubMed ID: 8496834
    [Abstract] [Full Text] [Related]

  • 57. Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation.
    Yaromina A, Thames H, Zhou X, Hering S, Eicheler W, Dörfler A, Leichtner T, Zips D, Baumann M.
    Radiother Oncol; 2010 Jul 01; 96(1):116-22. PubMed ID: 20570380
    [Abstract] [Full Text] [Related]

  • 58. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation.
    Wang J, Biedermann KA, Brown JM.
    Cancer Res; 1992 Aug 15; 52(16):4473-7. PubMed ID: 1643639
    [Abstract] [Full Text] [Related]

  • 59. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
    Radiat Med; 1995 Aug 15; 13(6):291-5. PubMed ID: 8850370
    [Abstract] [Full Text] [Related]

  • 60. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
    Klein C, Dokic I, Mairani A, Mein S, Brons S, Häring P, Haberer T, Jäkel O, Zimmermann A, Zenke F, Blaukat A, Debus J, Abdollahi A.
    Radiat Oncol; 2017 Dec 29; 12(1):208. PubMed ID: 29287602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.